ENTRY       D04965                      Drug
NAME        Perphenazine hydrochloride;
            Perphenazine dihydrochloride;
            PZC intramuscular injection (TN)
FORMULA     C21H26ClN3OS. 2HCl
EXACT_MASS  475.1019
MOL_WEIGHT  476.8905
CLASS       Neuropsychiatric agent
             DG01478  Dopamine antagonist
              DG01474  Dopamine D2-receptor antagonist
             DG03200  Antipsychotic agent
              DG01905  Phenothiazine antipsychotics
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
REMARK      Therapeutic category: 1172
            ATC code: N05AB03
            Chemical structure group: DG00875
            Product (DG00875): D00503<JP/US> D02037<JP> D04038<JP> D04965<JP>
EFFICACY    Antipsychotic, Dopamine D2 receptor antagonist
COMMENT     Phenothiazine derivative
TARGET      DRD2 [HSA:1813] [KO:K04145]
  PATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction
            hsa04728(1813)  Dopaminergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07029  Antipsychotics - phenothiazines
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05A ANTIPSYCHOTICS
                N05AB Phenothiazines with piperazine structure
                 N05AB03 Perphenazine
                  D04965  Perphenazine hydrochloride &lt;JP&gt;
            USP drug classification [BR:br08302]
             Antipsychotics
              1st Generation/Typical
               Perphenazine
                D04965  Perphenazine hydrochloride
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1172  Phenothiazines
                 D04965  Perphenazine hydrochloride
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00875  Perphenazine
                 D04965  Perphenazine hydrochloride
              DG03200  Antipsychotic agent
               DG01905  Phenothiazine antipsychotics
                DG00875  Perphenazine
                 D04965  Perphenazine hydrochloride
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00875  Perphenazine
                D04965  Perphenazine hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD2
                 D04965  Perphenazine hydrochloride &lt;JP&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04965
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00875  Perphenazine
              DG03200  Antipsychotic agent
               DG01905  Phenothiazine antipsychotics
                DG00875  Perphenazine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00875  Perphenazine
DBLINKS     CAS: 2015-28-3
            PubChem: 47206701
            LigandBox: D04965
            NIKKAJI: J220.090B
ATOM        29
            1   C8x C    14.1146  -15.4316
            2   C8x C    14.1146  -16.8355
            3   C8x C    15.3304  -17.5374
            4   C8y C    16.5462  -16.8355
            5   C8y C    16.5462  -15.4316
            6   C8x C    15.3304  -14.7297
            7   S2x S    17.7620  -17.5374
            8   C8y C    18.9778  -16.8355
            9   C8y C    18.9778  -15.4316
            10  N4y N    17.7620  -14.7297
            11  C8x C    20.1936  -17.5374
            12  C8x C    21.4094  -16.8355
            13  C8y C    21.4094  -15.4316
            14  C8x C    20.1936  -14.7297
            15  C1b C    17.7620  -13.3258
            16  C1b C    18.9799  -12.6227
            17  C1b C    20.1797  -13.3156
            18  N1y N    21.3698  -12.6285
            19  C1x C    22.5646  -13.3186
            20  C1x C    23.7804  -12.6167
            21  N1y N    23.7806  -11.2129
            22  C1x C    22.5858  -10.5229
            23  C1x C    21.3700  -11.2246
            24  C1b C    25.0088  -10.5038
            25  C1b C    26.2201  -11.2031
            26  O1a O    27.4046  -10.5193
            27  X   Cl   22.6293  -14.7274
            28  X   Cl   26.8100  -14.8400
            29  X   Cl   26.8100  -14.8400
BOND        30
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    8  11 2
            13   11  12 1
            14   12  13 2
            15   13  14 1
            16    9  14 2
            17   10  15 1
            18   15  16 1
            19   16  17 1
            20   17  18 1
            21   18  19 1
            22   19  20 1
            23   20  21 1
            24   21  22 1
            25   22  23 1
            26   18  23 1
            27   21  24 1
            28   24  25 1
            29   25  26 1
            30   13  27 1
BRACKET     1    25.3400  -16.0300   25.3400  -13.7200
            1    27.7900  -13.7200   27.7900  -16.0300
            1  2
  ORIGINAL  1   28
  REPEAT    1   29
///
